Article PDF
Avoid common mistakes on your manuscript.
References
Bianchine JR, Malaraeg PV, Lasagna L, Azamoff DL, Brunk F, Hvidberg EF, Owen JA: Drugs as etiologic factors in the Stevens-Johnson syndrome. American Journal of Medicine 1968, 44: 390–405.
Moore N, Biour M, Paux G, Loupi E, Begaud B, Boismare F, Royer RJ: Adverse drug reaction monitoring: doing it the French way. Lancet 1985, ii: 1056–1058.
Cassel GH, Cole BC: Mycoplasma as agents of human disease. New England Journal of Medicine 1981, 204: 80–89.
Ludlam GB, Bridges JB, Benn EC: Association of Stevens-Johnson syndrome with antibody forMycoplasma pneumoniae. Lancet 1964, i: 958–959.
Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC: Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Archives of Dermatology 1993, 129: 92–96.
Werblovsky-Constantini N, Livshin R, Burstein M, Zeligwski A, Tur-Kaspa R: Toxic epidermal necrolysis associated with acute cholestatic viral hepatitis A. Journal of Clinical Gastroenterology 1989, 11: 691–693.
Roujeau JC, Guillaume JC, Fabre JP, Penso D, Fléchet ML, Girre JP: Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981–1985. Archives of Dermatology 1990, 126: 37–42.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fournier, S., Bastuji-Garin, S., Mentec, H. et al. Toxic epidermal necrolysis associated withMycoplasma pneumoniae infection. Eur. J. Clin. Microbiol. Infect. Dis. 14, 558–559 (1995). https://doi.org/10.1007/BF02113442
Issue Date:
DOI: https://doi.org/10.1007/BF02113442